3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Turcot syndrome
1
Rhabdoid Tumor
1
Pathologic Complete Response
1
Neuroectodermal Tumors, Primitive
1
Nasopharyngeal Carcinoma
1
Medulloblastoma
1
Lung Neoplasms
1
Esophagitis
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Anus Neoplasms
1
Interventions
ruxolitinib
7
fludarabine phosphate
3
bomedemstat
3
Whole-Body Irradiation
3
Tacrolimus
3
Specimen Handling
3
Mycophenolic Acid
3
Cyclophosphamide
3
Biopsy
3
fludarabine
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Melphalan
2
Injections
2
Busulfan
2
venetoclax
1
veliparib
1
piperine
1
pevonedistat
1
iadademstat
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
anagrelide
1
X-Rays
1
Valganciclovir
1
Transplantation
1
Topotecan
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
Induction Chemotherapy
×
1 year
×
Clear all
No trials found.